BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28934138)

  • 1. Inhibitory Effects of Culinary Herbs and Spices on the Growth of HCA-7 Colorectal Cancer Cells and Their COX-2 Expression.
    Jaksevicius A; Carew M; Mistry C; Modjtahedi H; Opara EI
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28934138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
    Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
    Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
    Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumorigenic activity of five culinary and medicinal herbs grown under greenhouse conditions and their combination effects.
    Yi W; Wetzstein HY
    J Sci Food Agric; 2011 Aug; 91(10):1849-54. PubMed ID: 21452174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.
    Gowda R; Sharma A; Robertson GP
    Cancer Lett; 2017 Jan; 385():243-250. PubMed ID: 27769779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
    Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
    Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms.
    Stolfi C; Franzè E; Monteleone I; Caruso R; Franceschilli L; Sileri P; Sica GS; Gaspari AL; Del Vecchio Blanco G; Pallone F; Monteleone G
    Clin Sci (Lond); 2012 Sep; 123(5):295-306. PubMed ID: 22435743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costunolide Induces Apoptosis through Generation of ROS and Activation of P53 in Human Esophageal Cancer Eca-109 Cells.
    Hua P; Sun M; Zhang G; Zhang Y; Song G; Liu Z; Li X; Zhang X; Li B
    J Biochem Mol Toxicol; 2016 Sep; 30(9):462-9. PubMed ID: 27078502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
    Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN
    World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC; Kania J; Burnat G; Hahn EG
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
    Lin J; Hsiao PW; Chiu TH; Chao JI
    Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells.
    Chang SH; Bae JH; Hong DP; Choi KD; Kim SC; Her E; Kim SH; Kang CD
    J Ethnopharmacol; 2010 Jul; 130(2):248-54. PubMed ID: 20438825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of selective cyclooxygenase-2 inhibitors in inhibiting proliferation and induction of apoptosis in oral squamous cell carcinoma.
    Ko SH; Choi GJ; Lee JH; Han YA; Lim SJ; Kim SH
    Oncol Rep; 2008 Feb; 19(2):425-33. PubMed ID: 18202791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenolcarboxylic acids from medicinal herbs exert anticancer effects through disruption of COX-2 activity.
    Tao L; Wang S; Zhao Y; Sheng X; Wang A; Zheng S; Lu Y
    Phytomedicine; 2014 Sep; 21(11):1473-82. PubMed ID: 24916702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions.
    Liang D; Qin Y; Zhao W; Zhai X; Guo Z; Wang R; Tong L; Lin L; Chen H; Wong YC; Zhong Z
    Cancer Lett; 2011 Nov; 310(1):69-76. PubMed ID: 21794975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.